Can HIV p24 be a suitable scaffold for presenting Env antigens?
作者信息
Buonaguro Luigi, Tagliamonte Maria, Tornesello Maria Lina, Buonaguro Franco M
出版信息
Clin Vaccine Immunol. 2011 Nov;18(11):2003-4. doi: 10.1128/CVI.05326-11. Epub 2011 Sep 7.
Abstract
摘要
相似文献
1
Can HIV p24 be a suitable scaffold for presenting Env antigens?HIV p24能否成为呈递Env抗原的合适支架？
Clin Vaccine Immunol. 2011 Nov;18(11):2003-4. doi: 10.1128/CVI.05326-11. Epub 2011 Sep 7.
2
Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.纯化的化学交联HIV-1刺突的免疫原性展示
J Virol. 2015 Jul;89(13):6725-45. doi: 10.1128/JVI.03738-14. Epub 2015 Apr 15.
3
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.基于中和作用的设计，产生了对 CH235 谱系 CD4bs 广谱中和抗体的未突变共同祖先具有高亲和力的 HIV-1 包膜三聚体。
PLoS Pathog. 2019 Sep 17;15(9):e1008026. doi: 10.1371/journal.ppat.1008026. eCollection 2019 Sep.
4
A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.一种基于HIV-1 B亚型env基因的类天然SOSIP.664三聚体。
J Virol. 2015 Mar;89(6):3380-95. doi: 10.1128/JVI.03473-14. Epub 2015 Jan 14.
5
Construction and immunogenicity of Salmonella vaccine vector expressing HIV-1 antigen and MCP3.表达HIV-1抗原和MCP3的沙门氏菌疫苗载体的构建及其免疫原性
Acta Microbiol Immunol Hung. 2009 Dec;56(4):403-15. doi: 10.1556/AMicr.56.2009.4.10.
6
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.
7
Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop.V1 环缺失或异源取代诱导可溶性三聚体人免疫缺陷病毒 1 型包膜蛋白免疫原性改变。
J Virol. 2010 Oct;84(19):9932-46. doi: 10.1128/JVI.00868-10. Epub 2010 Jul 21.
8
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.在铁蛋白纳米颗粒上呈现类似天然的HIV-1包膜三聚体可提高其免疫原性。
Retrovirology. 2015 Sep 26;12:82. doi: 10.1186/s12977-015-0210-4.
9
The HIV-1 Env trimer in HD.高密度下的HIV-1包膜三聚体。
Structure. 2014 Jul 8;22(7):935-6. doi: 10.1016/j.str.2014.06.004.
10
Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design.HIV 包膜与尖端靶向中和抗体谱系的共同进化为疫苗设计提供了基准。
Cell Rep. 2018 Jun 12;23(11):3249-3261. doi: 10.1016/j.celrep.2018.05.046.
引用本文的文献
1
Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses .利用人类免疫缺陷病毒1型（HIV-1）p17蛋白与抗gp41 2F5抗体之间的天然交叉反应性诱导HIV-1中和反应
Front Immunol. 2017 Jun 30;8:770. doi: 10.3389/fimmu.2017.00770. eCollection 2017.
2
HIV p24 as scaffold for presenting conformational HIV Env antigens.HIV p24 作为展示构象 HIV 包膜抗原的支架。
PLoS One. 2012;7(8):e43318. doi: 10.1371/journal.pone.0043318. Epub 2012 Aug 17.
本文引用的文献
1
Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant.异源表位支架初免-加强免疫聚焦于 HIV-1 gp41 2F5 中和决定簇的 B 细胞反应。
PLoS One. 2011 Jan 26;6(1):e16074. doi: 10.1371/journal.pone.0016074.
2
Elicitation of structure-specific antibodies by epitope scaffolds.表位支架诱导结构特异性抗体。
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):17880-7. doi: 10.1073/pnas.1004728107. Epub 2010 Sep 27.
3
Viral evolution and escape during acute HIV-1 infection.急性 HIV-1 感染期间的病毒进化和逃逸。
J Infect Dis. 2010 Oct 15;202 Suppl 2(Suppl 2):S309-14. doi: 10.1086/655653.
4
A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.在一些 HIV-1 感染者中，有限数量的抗体特异性可介导广泛而有效的血清中和作用。
PLoS Pathog. 2010 Aug 5;6(8):e1001028. doi: 10.1371/journal.ppat.1001028.
5
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.基于结构的设计和免疫原性分析，利用 CTB 支架展示 HIV-1 gp120 V3 环。
Virology. 2010 Sep 30;405(2):513-23. doi: 10.1016/j.virol.2010.06.027. Epub 2010 Jul 21.
6
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.包膜的合理设计鉴定出针对 HIV-1 的广泛中和人源单克隆抗体。
Science. 2010 Aug 13;329(5993):856-61. doi: 10.1126/science.1187659. Epub 2010 Jul 8.
7
Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus.六聚体衣壳的二硫键稳定化：人类免疫缺陷病毒。
J Mol Biol. 2010 Sep 3;401(5):985-95. doi: 10.1016/j.jmb.2010.06.042. Epub 2010 Jun 26.
8
Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects.HIV-1 感染者体内广谱中和抗体的表位特异性。
Vaccine. 2010 May 26;28 Suppl 2:B8-12. doi: 10.1016/j.vaccine.2009.07.085.
9
Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.艾滋病疫苗 2009 会议报告：艾滋病毒疫苗研发进展
Lancet Infect Dis. 2010 May;10(5):305-16. doi: 10.1016/S1473-3099(10)70069-4.
10
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.分析 HIV-1 感染者的记忆 B 细胞反应并分离具有广泛中和广度的新型单克隆抗体。
PLoS One. 2010 Jan 20;5(1):e8805. doi: 10.1371/journal.pone.0008805.
Zotero 插件